#United States #New York #Class Action #Shareholder Rights #PepGen Inc

Overview

Recent news has emerged that a class action lawsuit is being initiated against PepGen Inc. (NASDAQ: PEPG), a biotechnology company focused on developing innovative therapies. Shareholders who acquired shares during a specified class period are being encouraged to register for potential participation. The Gross Law Firm is leading this effort, highlighting significant allegations regarding misleading statements issued by the company.

Details of the Class Action

According to a notice from The Gross Law Firm dated July 3, 2025, shareholders who purchased PEPG shares from March 7, 2024, to March 3, 2025, are particularly urged to take action. The lawsuit arises from claims that PepGen’s management provided materially false information about the effectiveness of their lead product candidate, PGN-EDO51. These statements allegedly inflated the company’s stock price, leading investors to believe in the viability of PGN-EDO51 without proper disclosure of critical safety and efficacy data.

Allegations Against PepGen

The complaint states that:
1. PepGen misrepresented the efficacy of PGN-EDO51, suggesting it was safer than evidence would support.
2. The phase two clinical trial, referred to as the CONNECT2 study, was reportedly flawed and potentially dangerous, compromising its suitability for U.S. Food and Drug Administration (FDA) approval.
3. These misleading statements led to exaggerated clinical, regulatory, and commercial prospects for PGN-EDO51, consequently disappointing investors when the reality came to light.

These serious allegations have led to a call for shareholders to act quickly in the interest of protecting their investments and holding the company accountable for its actions.

Importance of Joining the Class Action

Participating in this class action suit offers shareholders a path to potentially recover losses incurred due to deceptive practices. While shareholders can seek to be appointed as lead plaintiff, they are not required to do so to benefit from any recovery in the event of a settlement or judgment in favor of the shareholders.

Next Steps for Interested Shareholders

• - Deadline: The cutoff date for registering to take part in the class action is August 8, 2025. Shareholders must act swiftly to ensure their eligibility.
• - Registration Process: Interested shareholders can initiate the registration process through a dedicated link provided by The Gross Law Firm. By registering, shareholders will also gain access to portfolio monitoring software, allowing them to receive updates regarding the case’s progress.

Why Choose The Gross Law Firm?

The Gross Law Firm has established itself as a reputable class action law firm, dedicated to advocating for investors' rights. Their commitment centers on ensuring that companies are held accountable for fraudulent practices that harm investors. By working with them, shareholders can take proactive steps toward securing justice and potential financial recovery.

Final Remarks

If you are a shareholder of PepGen Inc. within the specified timeframe, it is imperative to consider joining the class action as soon as possible. This legal endeavor aims to empower shareholders and address the concerns raised by the alleged misrepresentations. As the deadline approaches, proactive engagement is key to safeguarding your interests in PepGen Inc.

For more information and to register for the class action, visit The Gross Law Firm's website or contact them directly at their New York office.